Skip to main content
Lime Chemicals Ltd. logo

Lime Chemicals Ltd. — Investor Relations & Filings

Ticker · 507759 ISIN · INE891G01011 BSE.NS Manufacturing
Open in API
Filings indexed 274 across all filing types
Latest filing 2025-02-14 Regulatory Filings
Country IN India
Listing BSE.NS 507759

About Lime Chemicals Ltd.

https://www.limechem.com/

Lime Chemicals Ltd. specializes in the production of high-quality Calcium Carbonate, specifically focusing on Precipitated Calcium Carbonate (PCC) and Activated Calcium Carbonate. The company operates manufacturing facilities that utilize advanced carbonation processes to ensure high purity and specific particle size distributions. Its product portfolio serves a wide range of industrial applications, including the formulation of oral care products like toothpaste, pharmaceutical excipients, and fillers for the polymer, rubber, and paper sectors. The company provides various grades tailored to meet stringent technical specifications for opacity, brightness, and chemical stability. By maintaining a focus on research and development, the firm supports specialized requirements in the plastics and coatings industries, positioning itself as a key supplier of mineral-based functional additives.

Recent filings

Filing Released Lang Actions
Submitting the unaudited financial results of the Company for the quarter ended on 31st December 2024 approved by the Board of Directors at their meeting held on 14th February 2025.
Regulatory Filings
2025-02-14 English
The unaudited financial results for the quarter ended on 31st December 2024 approved by the Board of Directors at their meeting held on 14th February 2025 is attached herewith.
Regulatory Filings
2025-02-14 English
LIME CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve A meeting of the Board of Directors ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchange about an upcoming Board Meeting to approve un-audited financial results for the quarter ended December 31, 2024. It does not contain the financial results themselves, only an announcement of the meeting date and agenda. The document length is only 984 characters, indicating it is a brief announcement rather than a full report. According to the rules, such announcements about meetings to approve financial results are classified as Regulatory Filings (RNS) because they do not contain substantive financial data or the actual report.
2025-02-03 English
Submitting the Certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended on 31st December 2024.
Regulatory Filings Classification · 95% confidence The document is a certificate submitted under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2024. It is a compliance certificate from the Registrar and Transfer Agent confirming dematerialization and listing of securities. The document is short (2700 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance certificates and regulatory announcements that do not fit other specific categories.
2025-01-14 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sparrow Asia Diversified Opportunities Fund
Regulatory Filings
2025-01-07 English
Trading window will be closed from January 01, 2025 till 48 hours from the declaration of un-audited financial results of the Company for the quarter ending on 31st December 2024.
Regulatory Filings Classification · 95% confidence The document is a letter from the company secretary to the stock exchange notifying the closure of the trading window in compliance with the company's code of conduct related to trading by designated persons. It references the upcoming declaration of unaudited financial results for the quarter ending December 31, 2024, but does not contain any financial data or results itself. The document is short (1220 characters) and serves as an announcement related to trading restrictions rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and regulatory announcements that do not fit other specific categories.
2024-12-30 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.